Evaluation of TWEAK in Plaque Psoriasis and Psoriatic Arthritis Patients - Trial NCT06370156
Access comprehensive clinical trial information for NCT06370156 through Pure Global AI's free database. This phase not specified trial is sponsored by Egymedicalpedia and is currently Not yet recruiting. The study focuses on Plaque Psoriasis. Target enrollment is 100 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Egymedicalpedia
Timeline & Enrollment
N/A
Jun 01, 2024
Jun 10, 2025
Primary Outcome
Treatment of psoriasis vulgaris and psoriatic arthritis
Summary
Psoriasis vulgaris is associated with significant comorbidity including depression, increased
 risk of cardiovascular events, diminished quality of life, as well as overall increased
 mortality.
 
 Moreover, concomitant psoriatic arthritis is present in up to 40% of psoriasis patients or
 will develop in the future.
 
 To enhance quality of life and potentially lower the risk of concomitant disease in psoriasis
 patients, effective treatment of this immune-mediated systemic inflammatory disease is
 required
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06370156
Non-Device Trial